ARCHIVES

Phase III Study Evaluating Halaven Fails To Meet Primary Endpoints

This article is from The Cancer Letter archive.

Vol. 35 No. 7 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

Health Organizations: ACS Panel Urges Mammography For Women 40-49

March 14, 1997

Clinical Education Program Phase Out Opposed By NCAB Committee

February 14, 1986

U.S., Canada Begin ExCel Trial To Evaluate Aromasin For Breast Cancer Prevention

April 29, 2005

Abbott Seeks Applicants For Young Investigators Awards Program

January 4, 1991

PHS Plans Revitalization of Commissioned Corps

July 11, 2003

A Biostatistics Paper Alleges Potential Harm To Patients In Two Duke Clinical Studies

October 2, 2009